Senseonics Unveils Strategy to Accelerate Growth With One-Year CGM System
I'm PortAI, I can summarize articles.
Senseonics Holdings Inc. has unveiled its strategy to accelerate growth in the global continuous glucose monitoring (CGM) market, projected to reach $13.5 billion by 2025. The company is promoting its Eversense 365 system, the first one-year CGM, while addressing patient concerns like sensor longevity and accuracy. Their roadmap includes increasing awareness, expanding market access, and enhancing user experience through targeted marketing and optimized commercial capacity. Senseonics aims to drive revenue growth in this underpenetrated market.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments